News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Jarushka Naidoo: Important paper on incidence and outcomes of EGFR+ NSCLC
Jarushka Naidoo/X
Dec 25, 2024, 02:57

Jarushka Naidoo: Important paper on incidence and outcomes of EGFR+ NSCLC

Jarushka Naidoo, Thoracic Oncologist at the Beaumont Hospital Dublin (Ireland), posted the following on X:

“Important paper on incidence and outcomes of molecular subtypes of EGFR+ NSCLC in JTO and JTO CRR.

– 5,212 patients with EGFR+ NSCLC.
– 8.9% had uncommon EGFR mutations.
– Median time on TKIs 4.1m vs 10.9m (common) and 12.4m (compound).

Congratulations Alfredo Addeo et al.”

Decoding the Clinical and Molecular Signatures of EGFR Common, Compound, and Uncommon Mutations in Non-Small Cell Lung Cancer.

Authors: Daniele Tavernari, Maxime Borgeaud, Ximeng Liu, Parikh Kaushal, Xiuning Le, Giovanni Ciriello, Alfredo Addeo

Jarushka Naidoo

Alfredo Addeo Beaumont Hospital cancer Daniele Tavernari EGFR+ NSCLC Giovanni Ciriello Jarushka Naidoo JTO and JTO CRR Maxime Borgeaud OncoDaily Oncology Parikh Kaushal Ximeng Liu Xiuning Le
Special Coverage
Insight
Dec 25, 2024, 02:57
Jarushka Naidoo: Important paper on incidence and outcomes of EGFR+ NSCLC
Insight
Dec 25, 2024, 02:41
Correlating PSA Dynamics with Outcomes of Lutetium-177-PSMA-617 Treatment - European Urology
Science
Dec 25, 2024, 02:35
Hospital Participation in the Acute Hospital Care at Home Waiver Program by Hashem Zikry et al.
Science
Dec 25, 2024, 01:52
Erman Akkus: Role of PD-L1 expression in advanced esophageal SCC by Manavi Sachdeva et al.
Blog
Dec 25, 2024, 01:50
Results of SISAQOL-IMI: Advancing Patient-Reported Outcomes Research
Science
Dec 24, 2024, 23:45
Tatiana Prowell: Genomic profiling performed on 822 breast cancer brain metastases by Athina Giannoudis et al.
Blog
Dec 24, 2024, 23:42
Extending the pandemic-era telehealth flexibilities in Medicare - ASCO
Science
Dec 24, 2024, 23:36
Drew Moghanaki: An updated report from the MISSILE study team
Science
Dec 24, 2024, 23:31
Bladder-sparing Therapy for BCG-unresponsive Non-muscle-invasive Bladder Cancer
Insight
Dec 24, 2024, 23:29
Mark Bolton: What if patients switch treatment at progression
Blog
Dec 24, 2024, 23:27
Give the gift of hope, brighter futures, and more time for patients and families - The Leukemia And Lymphoma Society
Blog
Dec 24, 2024, 23:24
Shaban Juma: Community health education is the key component in disease prevention